NMD4C Welcomes Two New Staff Members
The NMD4C recently welcomed two new members to the network coordination team! Marine Christin, PhD joins us as the new Pre-Clinical Science Coordinator, and Maria Masnata, PhD joins as the Clinical Trials and Community of Practice Manager.
Marine Christin, PhD | Pre-Clinical Science Coordinator
After graduating with a BSc and an MSc in Pharmacology, Physiology, and Neurobiology, Marine Christin obtained her Ph.D. in Cellular and Molecular Interactions from Nice Sophia-Antipolis University. During her postdoctoral fellowship at McGill University, her research focused on investigating the role of ion channels in pain. Currently serving as the Program Manager for the McGill Regenerative Medicine Network, she oversees and coordinates research and educational activities within the Network.
Within the NMD4C, Marine oversees the coordination of the animal and cell-based research activities, including the basic research summer school.
Maria Masnata, PhD | Clinical Trials and Community of Practice Manager
Maria has over 10 years of experience in clinical and in preclinical research in the field of the Neurosciences. She received her M.Sc. in Pharmacy from University of Cagliari in 2015 and her Ph.D. in Neurobiology from Université Laval in 2021. Maria developed extensive experience in clinical research and project management during her previous role as the Assistant Manager of the Investigator-Initiated Trial team of the Clinical Research Unit at The Montreal Neurological Institute/Hospital (McGill University).
With a proven track record of managing and coordinating projects leading to Health Canada-approved clinical trials, peer-reviewed publications and national/international presentations, Maria is committed to advancing healthcare and advocating for scientific innovation in her role as Clinical Trials and Community of Practice Manager.
Read next...
Zolgensma® Safety Update and CPNG Guidance for Families
The Canadian Pediatric Neuromuscular Group (CPNG) has issued a statement for families regarding recent reports of tumours in children treated with Zolgensma® (onasemnogene abeparvovec) gene therapy for spinal muscular atrophy (SMA). The statement outlines current evidence, considerations for follow-up care, and information for families and healthcare providers.
Could You Be Our Next Awardee? Meet Jules Granet, NMD4C’s 2026 Publication of the Year Awardee
Nominations are open till by 18 January 2027!
In 2026, Jules Granet, a PhD Candidate at McGill University and trainee in Dr. Natasha Chang’s laboratory received an NMD4C Publication of the Year Award for research investigating how muscle stem cell dysfunction contributes to impaired muscle regeneration in Duchenne muscular dystrophy. Nominate yourself or a neuromuscular colleague whose research, clinical care, leadership, advocacy, or community contributions deserve to be recognized.
Early Bird Registration Now Open: 8th Ottawa International Conference On Neuromuscular Disease & Biology
We are happy to announce that early bird registration is now open for the 8th Ottawa International Conference On Neuromuscular Disease & Biology which will be held on October 14-16, 2027 at the Fairmont Château Laurier in Ottawa, Canada. Now under the leadership of NMD4C Investigators; Dr. Mireille Khacho, Dr. Hanns Lochmuller, Dr. Bernard Jasmin, and Dr. Rashmi Kothary.